These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32453776)

  • 1. Correction: Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
    Togano S; Yashiro M; Miki Y; Yamamoto Y; Sera T; Kushitani Y; Sugimoto A; Kushiyama S; Nishimura S; Kuroda K; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Tanaka S; Ohira M
    PLoS One; 2020; 15(5):e0233743. PubMed ID: 32453776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
    Togano S; Yashiro M; Miki Y; Yamamoto Y; Sera T; Kushitani Y; Sugimoto A; Kushiyama S; Nishimura S; Kuroda K; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Tanaka S; Ohira M
    PLoS One; 2020; 15(1):e0225958. PubMed ID: 31940352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal recurrence in serosa-negative gastric adenocarcinoma after curative surgery.
    Wu CC; Chen JH; Huang KH; Fang WL; Wu CW; Lo SS; Hsieh MC; Shen KH; Li AF
    Hepatogastroenterology; 2011; 58(109):1119-22. PubMed ID: 21937361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
    Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
    Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
    Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
    Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection.
    Chae HD; Kim IH
    Scand J Gastroenterol; 2016 Aug; 51(8):956-60. PubMed ID: 27162096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?
    Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE
    Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal recurrence in gastric cancer following curative resection can be predicted by postoperative but not preoperative biomarkers: a single-institution study of 320 cases.
    Wu F; Shi C; Wu R; Huang Z; Chen Q
    Oncotarget; 2017 Sep; 8(44):78120-78132. PubMed ID: 29100454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
    Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
    Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?
    Ribeiro U; Safatle-Ribeiro AV; Zilberstein B; Mucerino D; Yagi OK; Bresciani CC; Jacob CE; Iryia K; Gama-Rodrigues J
    J Gastrointest Surg; 2006 Feb; 10(2):170-6, discussion 176-7. PubMed ID: 16455447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of IL-17 mRNA expression in peritoneal lavage in gastric cancer patients who underwent curative resection.
    Iida T; Iwahashi M; Katsuda M; Ishida K; Nakamori M; Nakamura M; Naka T; Ojima T; Ueda K; Hayata K; Yasuoka H; Yamaue H
    Oncol Rep; 2014 Feb; 31(2):605-12. PubMed ID: 24337702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal recurrence of gastric adenocarcinoma after curative resection.
    Lee CC; Lo SS; Wu CW; Shen KH; Li AF; Hsieh MC; Lui WY
    Hepatogastroenterology; 2003; 50(53):1720-2. PubMed ID: 14571826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
    Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
    Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).
    Kim JY; Bae HS
    Gastric Cancer; 2001; 4(1):27-33. PubMed ID: 11706624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
    Lee JW; Jo K; Cho A; Noh SH; Lee JD; Yun M
    J Nucl Med; 2015 Oct; 56(10):1494-500. PubMed ID: 26251414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of hepatocyte growth factor, transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrative gastric cancer and their relations with defluxion of gastric cancer cell and prognosis].
    Li CF; Wei YZ; Xue YW
    Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):206-9. PubMed ID: 19563076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
    Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
    Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural Invasion is a Significant Contributor to Peritoneal Recurrence in Signet Ring Cell Gastric Carcinoma.
    Lee D; Son SY; Kim YB; Han SU; Hur H
    Ann Surg Oncol; 2018 May; 25(5):1167-1175. PubMed ID: 29450754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.